ANI PHARMS INC FDA Approval ANDA 206964

ANDA 206964

ANI PHARMS INC

FDA Drug Application

Application #206964

Application Sponsors

ANDA 206964ANI PHARMS INC

Marketing Status

Discontinued001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL25MG;200MG0ASPIRIN AND DIPYRIDAMOLEASPIRIN; DIPYRIDAMOLE

FDA Submissions

UNKNOWN; ORIG1AP2017-01-18STANDARD
LABELING; LabelingSUPPL7AP2019-04-16STANDARD

Submissions Property Types

ORIG1Null7
SUPPL7Null15

CDER Filings

ANI PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206964
            [companyName] => ANI PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ASPIRIN AND DIPYRIDAMOLE","activeIngredients":"ASPIRIN; DIPYRIDAMOLE","strength":"25MG;200MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/18\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"04\/16\/2019","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-04-16
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.